Wellbeing
AI & ML
Nanox drops 2026 guidance as imaging roll-out lag fuels going-concern
The Israeli medical-imaging company withdraws its annual revenue target as deployment delays and a $14m quarterly loss test its cash runway.
The Israeli medical-imaging company withdraws its annual revenue target as deployment delays and a $14m quarterly loss test its cash runway.